Evidence map›Paper›PMID 34095102›Full record

ArticleFrontiers in bioengineering and biotechnology2021

Iron-Palladium Decorated Carbon Nanotubes Achieve Radiosensitization via Reactive Oxygen Species Burst.

Shengnan Yang, Yiling Yang, Yi Yang, Xiangya Zhao, Qian Wang, Bing Li, Ling Dong, Rui Tian, Zhirong Bao

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in bioengineering and biotechnology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Shengnan YangDepartment of Geriatric Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Yiling YangDepartment of Ultrasound, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Yi YangDepartment of Geriatric Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Xiangya ZhaoDepartment of Geriatric Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Qian WangDepartment of Geriatric Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Bing LiDepartment of Geriatric Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Ling DongDepartment of Geriatric Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Rui TianDepartment of Geriatric Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Zhirong BaoHubei Key Laboratory of Tumor Biological Behaviors, Department of Radiation and Medical Oncology, Hubei Cancer Clinical Study Center, Zhongnan Hospital of Wuhan University, Wuhan, China.
First Affiliated Hospital of Zhengzhou University · CNWuhan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Radiotherapy is recommended as a modality for cancer treatment in clinic. However, cancerous cells were resistant to therapeutic irradiation due to its DNA repair. In this work, single-walled carbon nanotubes with unique physical properties of hollow structures and high specific surface area were introduced as carrier for iron-palladium (FePd) to obtain iron-palladium decorated carbon nanotubes (FePd@CNTs). On one hand, FePd nanoparticles possess significant ability in radiosensitization as previously reported. On the other hand, carbon nanotubes offer higher efficiency in crossing biological barriers, inducing the accumulation and retention of FePd nanoparticles within tumor tissue. In order to verify the radiosensitization effect of FePd@CNTs, both

Indexed as

carbon nanotubesFePd NPsnanomedicineradiotherapyretention

Identifiers

PMID34095102
PMCPMC8176102
OpenAlexW3160455500

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.